Health ❯Healthcare ❯Clinical Research

Drug Efficacy

Clinical Trials Side Effects Lecanemab Antibiotic Use in STIs Amyloid-Aggregates Health Outcomes Heart Health Patient Outcomes Ozempic and Alzheimer's Disease

EU Approves First Alzheimer's Drug Targeting Disease Progression

Lecanemab, designed to slow early-stage cognitive decline, faces stringent eligibility criteria and logistical hurdles before rollout.

EU Commission Approves First Alzheimer’s Therapy Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks